Cited by 2,050HIV Research and TreatmentHIV/AIDS drug development and treatmentInfectious Diseases and Tuberculosis

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

Chun, Tae-Wook, Carruth, Lucy, Finzi, Diana, Shen, Xuefei, DiGiuseppe, Joseph A., Taylor, Harry, Hermankova, Monika, Chadwick, Karen, Margolick, Joseph, Quinn, Thomas C., Kuo, Yen-Hong, Brookmeyer, Ronald, Zeiger, Martha A., Barditch-Crovo, Patricia, Siliciano, Robert F.·1997·Nature

DOI 10.1038/387183a0

Open this paper in CoChat — free account

Abstract

The capacity of HIV-1 to establish latent infection of CD4+ T cells may allow viral persistence despite immune responses and antiretroviral therapy. Measurements of infectious virus and viral RNA in plasma and of infectious virus, viral DNA and viral messenger RNA species in infected cells all suggest that HIV-1 replication continues throughout the course of infection. Uncertainty remains over what fraction of CD4+ T cells are infected and whether there are latent reservoirs for the virus. We show here that during the asymptomatic phase of infection there is an extremely low total body load of latently infected resting CD4+ T cells with replication-competent integrated provirus (<10(7) cells). The most prevalent form of HIV-1 DNA in resting and activated CD4+ T cells is a full-length, linear, unintegrated form that is not replication competent. The infection progresses even though at any given time in the lymphoid tissues integrated HIV-1 DNA is present in only a minute fraction of the susceptible populations, including resting and activated CD4+ T cells and macrophages.

Integrity signals

Registry

Crossref · 10.1038/387183a0

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., & Markowitz, M. H. (1995) · Nature · doi:10.1038/373123a0 · Cited by 4,261
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
Perelson, A. S., Neumann, A. U., Markowitz, M. H., Leonard, J. M., & Ho, D. D. (1996) · Science · doi:10.1126/science.271.5255.1582 · Cited by 3,533
Viral dynamics in human immunodeficiency virus type 1 infection
Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., et al. (1995) · Nature · doi:10.1038/373117a0 · Cited by 3,259
Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma
Mellors, J. W., Rinaldo, C. R., Gupta, P., White, R. M., Todd, J. A., & Kingsley, L. (1996) · Science · doi:10.1126/science.272.5265.1167 · Cited by 2,658
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
Coffin, J. M. (1995) · Science · doi:10.1126/science.7824947 · Cited by 1,963
Decay characteristics of HIV-1-infected compartments during combination therapy
Perelson, A. S., Essunger, P., Cao, Y., Vesanen, M., Hurley, A., Saksela, K., Markowitz, M. H., & Ho, D. D. (1997) · Nature · doi:10.1038/387188a0 · Cited by 1,861
The Role of Mononuclear Phagocytes in HTLV-III/LAV Infection
Gartner, S., Markovits, P., Markovitz, D. M., Kaplan, M. H., Gallo, R. C., & Popovič, M. (1986) · Science · doi:10.1126/science.3014648 · Cited by 1,808
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
Pantaleo, G., Graziosi, C., Demarest, J. F., Butini, L., Montroni, M., Fox, C. H., Orenstein, J. M., Kotler, D. P., & Fauci, A. S. (1993) · Nature · doi:10.1038/362355a0 · Cited by 1,808
HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
Zack, J. A., Arrigo, S. J., Weitsman, S. R., Go, A. S., Haislip, A., & Chen, I. S. Y. (1990) · Cell · doi:10.1016/0092-8674(90)90802-l · Cited by 1,517
Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS
Embretson, J. E., Zupancic, M., Ribas, J. L., Burke, A., Rácz, P., Tenner‐Racz, K., & Haase, A. T. (1993) · Nature · doi:10.1038/362359a0 · Cited by 1,419

Flagged first, then by citations

Show all 29 references

Sorted by citations

Items 801–900 of 1,000

The Complexity of HIV Persistence and Pathogenesis in the Lung Under Antiretroviral Therapy: Challenges Beyond AIDS
Almodóvar, S. (2014) · Viral Immunology · doi:10.1089/vim.2013.0130 · Cited by 39
Measurement of Human Immunodeficiency Virus Type 1 Preintegration Transcription by Using Rev-Dependent Rev-CEM Cells Reveals a Sizable Transcribing DNA Population Comparable to That from Proviral Templates
Iyer, S. R., Yu, D., Biancotto, A., Margolis, L. B., & Wu, Y. (2009) · Journal of Virology · doi:10.1128/jvi.00874-09 · Cited by 37
In vivo disruption of latent HSV by designer endonuclease therapy
Aubert, M., Madden, E. A., Loprieno, M. A., Feelixge, H. S. D. S., Stensland, L., Huang, M.-L. W., Greninger, A. L., Roychoudhury, P., Niyonzima, N., Nguyen, T., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.88468 · Cited by 38
Levels of HIV-infected peripheral blood cells remain stable throughout the natural history of HIV-1 infection
Cone, R. W., Gowland, P., Opravil, M., Grob, P. J., & Ledergerber, B. (1998) · AIDS · doi:10.1097/00002030-199817000-00005 · Cited by 37
Rapid, Transient Changes at the env Locus of Plasma Human Immunodeficiency Virus Type 1 Populations during the Emergence of Protease Inhibitor Resistance
Delwart, E., Pan, H., Neumann, A. U., & Markowitz, M. H. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2416-2421.1998 · Cited by 37
Persistence of intact HIV-1 proviruses in the brain during antiretroviral therapy
Sun, W., Rassadkina, Y., Gao, C., Collens, S. I., Lian, X., Solomon, I. H., Mukerji, S. S., Yu, X. G., & Lichterfeld, M. D. (2023) · eLife · doi:10.7554/elife.89837 · Cited by 36
Aging and HIV infection
Avelino‐Silva, V. I., Ho, Y.-L., Avelino‐Silva, T. J., & dos Santos, S. D. S. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.10.004 · Cited by 38
Patients on HAART often have an excess of unintegrated HIV DNA: Implications for monitoring reservoirs
Agosto, L. M., Liszewski, M. K., Mexas, A. M., Graf, E. H., Pace, M. J., Yu, J. J., Bhandoola, A., & O’Doherty, U. (2010) · Virology · doi:10.1016/j.virol.2010.08.024 · Cited by 38
The role of HIV integration in viral persistence: no more whistling past the proviral graveyard
Maldarelli, F. M. (2016) · Journal of Clinical Investigation · doi:10.1172/jci80564 · Cited by 39
Chromatin-Associated Regulation Of Hiv-1 Transcription
Quivy, V., de Walque, S., & Lint, C. M. V. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5466-1_17 · Cited by 36
Initiation of Antiretroviral Therapy During Recent HIV-1 Infection Results in Lower Residual Viral Reservoirs
Pires, A., Hardy, G. A. D., Gazzard, B., Gotch, F. M., & Imami, N. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200407010-00004 · Cited by 38
A Novel Assay Allows Genotyping of the Latent Reservoir for Human Immunodeficiency Virus Type 1 in the Resting CD4+T Cells of Viremic Patients
Monie, D., Simmons, R. P., Nettles, R. E., Kieffer, T. L., Zhou, Y., Zhang, H., Karmon, S. L., Ingersoll, R., Chadwick, K. R., Zhang, H., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.5185-5202.2005 · Cited by 36
Self-citation
The probability of HIV infection in a new host and its reduction with microbicides
Tuckwell, H. C., Shipman, P. D., & Perelson, A. S. (2008) · Mathematical Biosciences · doi:10.1016/j.mbs.2008.03.005 · Cited by 36
Effect of Latent Human Immunodeficiency Virus Infection on Cell Surface Phenotype
Brooks, D. G., & Zack, J. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.4.1673-1681.2002 · Cited by 36
Goals and milestones during treatment of HIV-1 infection with antiretroviral therapy: a pathogenesis-based perspective
Louie, M. J., & Markowitz, M. H. (2002) · Antiviral Research · doi:10.1016/s0166-3542(02)00022-0 · Cited by 36
Unintegrated HIV-1 provides an inducible and functional reservoir in untreated and highly active antiretroviral therapy-treated patients
Petitjean, G., Tabaa, Y. A., Tuaillon, É., Mettling, C., Baillat, V., Reynes, J., Segondy, M., & Vendrell, J. P. (2007) · Retrovirology · doi:10.1186/1742-4690-4-60 · Cited by 36
Highly active antiretroviral therapy with or without mycophenolate mofetil in treatment-naive HIV-1 patients
Sankatsing, S. U. C., Jurriaans, S., van Swieten, P., van Leth, F., Cornelissen, M. T. E., Miedema, F. F., Lange, J. M. A., Schuitemaker, H., & Prins, J. M. (2004) · AIDS · doi:10.1097/00002030-200409240-00008 · Cited by 36
Decelerating Decay of Latently Infected Cells during Prolonged Therapy for Human Immunodeficiency Virus Type 1 Infection
Müller, V., Vigueras-Gómez, J. F., & Bonhoeffer, S. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8963-8965.2002 · Cited by 37
What can we learn about human immunodeficiency virus infection from a study of lymphocytic choriomeningitis virus?
Klenerman, P., & Zinkernagel, R. M. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb01003.x · Cited by 36
Use of a stochastic model to develop understanding of the impact of different patterns of antiretroviral drug use on resistance development
Phillips, A. N., Youle, M. S., Johnson, M. A., & Loveday, C. (2001) · AIDS · doi:10.1097/00002030-200111230-00001 · Cited by 36
Cellular proviral HIV-DNA decline and viral isolation in naïve subjects with <5000 copies/ml of HIV-RNA and >500 × 106/l CD4 cells treated with highly active antiretroviral therapy
Andreoni, M., Parisi, S. G., Sarmati, L., Nicastri, E., Ercoli, L., Mancino, G., Sotgiu, G., Mannazzu, M., Trevenzoli, M., Tridente, G., et al. (2000) · AIDS · doi:10.1097/00002030-200001070-00003 · Cited by 36
Level of Human Immunodeficiency Virus DNA in Peripheral Blood Mononuclear Cells Correlates with Efficacy of Antiretroviral Therapy
McDermott, J. L., Giri, A. A., Martini, I., Bono, M. R., Giacomini, M. L., Campelli, A., Tagliaferro, L., Cara, A., & Varnier, O. E. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.7.2361-2365.1999 · Cited by 36
The Inhibitory Effect of RANTES on the Infection of Primary Macrophages by R5 Human Immunodeficiency Virus Type-1 Depends on the Macrophage Activation State
Amzazi, S., Ylisastigui, L., Bakri, Y., Rabehi, L., Gattegno, L., Parmentier, M., Gluckman, J. C., & Benjouad, A. (1998) · Virology · doi:10.1006/viro.1998.9452 · Cited by 36
HIV Type 1 Cervicovaginal Reservoirs in the Era of HAART
Nunnari, G., Sullivan, J., Xu, Y., Nyirjesy, P., Kulkosky, J., Cavert, W. P., Frank, I., & Pomerantz, R. J. (2005) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2005.21.714 · Cited by 35
Novel Pathway for Induction of Latent Virus from Resting CD4+T Cells in the Simian Immunodeficiency Virus/Macaque Model of Human Immunodeficiency Virus Type 1 Latency
Shen, A., Yang, H., Zhou, Y., Chase, A. J., Boyer, J., Zhang, H., Margolick, J. B., Zink, M. C., Clements, J. E., & Siliciano, R. F. (2006) · Journal of Virology · doi:10.1128/jvi.01396-06 · Cited by 36
Self-citation
The HIV-1-Specific Protein Casp8p41 Induces Death of Infected Cells through Bax/Bak
Sainski, A. M., Natesampillai, S., Cummins, N. W., Bren, G. D., Taylor, J., Saenz, D. T., Poeschla, E. M., & Badley, A. D. (2011) · Journal of Virology · doi:10.1128/jvi.02515-10 · Cited by 35
Reduction of the HIV-1 reservoir in resting CD4+ T-lymphocytes by high dosage intravenous immunoglobulin treatment: a proof-of-concept study
Lindkvist, A., Edén, A., Norström, M. M., Gonzalez, V. D., Nilsson, S., Svennerholm, B., Karlsson, A. C., Sandberg, J. K., Sönnerborg, A. B., & Gisslén, M. (2009) · AIDS Research and Therapy · doi:10.1186/1742-6405-6-15 · Cited by 35
A highly reproducible quantitative viral outgrowth assay for the measurement of the replication-competent latent HIV-1 reservoir
Fun, A., Mok, H. P., Wills, M. R., & Lever, A. M. L. (2017) · Scientific Reports · doi:10.1038/srep43231 · Cited by 38
Inhibition of highly productive HIV-1 infection in T cells, primary human macrophages, microglia, and astrocytes by Sargassum fusiforme
Paskaleva, E. E., Lin, X., Li, W., Cotter, R. L., Klein, M. T., Roberge, E., Yu, E., Clark, B., Veille, J.-C., Liu, Y., et al. (2006) · AIDS Research and Therapy · doi:10.1186/1742-6405-3-15 · Cited by 35
Persistent Abnormalities in Peripheral Blood Dendritic Cells and Monocytes from HIV-1-Positive Patients After 1 Year of Antiretroviral Therapy
Almeida, M. D. G., Cordero, M., Almeida, J., & Órfão, A. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000209896.82255.d3 · Cited by 35
Density-Dependent Decay in HIV-1 Dynamics
Holte, S., Melvin, A. J., Mullins, J. I., Tobin, N. H., & Frenkel, L. M. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000199233.69457.e4 · Cited by 35
HIV Persistence on Antiretroviral Therapy and Barriers to a Cure
Sung, J., & Margolis, D. M. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0484-2_7 · Cited by 36
Primary HIV Infection of Infants: The Effects of Somatic Growth on Lymphocyte and Virus Dynamics
Krogstad, P. A., Uíttenbogaart, C. H., Dickover, R. E., Bryson, Y. J., Plaeger, S. F., & Garfinkel, A. (1999) · Clinical Immunology · doi:10.1006/clim.1999.4728 · Cited by 36
Evaluation of PCR-based methods for the quantitation of integrated HIV-1 DNA
Kumar, R., Vandegraaff, N., Mundy, L. M., Burrell, C. J., & Li, P. (2002) · Journal of Virological Methods · doi:10.1016/s0166-0934(02)00105-2 · Cited by 35
Chemokine/CD4 receptor density ratios correlate with HIV replication in lymph node and peripheral blood of HIV-infected individuals
Nokta, M. A., Li, X.-D., Nichols, J. E., Mallén, M. A., Pou, A. M., Asmuth, D. M., & Pollard, R. B. (2001) · AIDS · doi:10.1097/00002030-200101260-00004 · Cited by 35
HIV 2-long terminal repeat circular DNA is stable in primary CD4+T Cells
Pace, M. J., Graf, E. H., & O'Doherty, U. (2013) · Virology · doi:10.1016/j.virol.2013.02.028 · Cited by 34
FIV establishes a latent infection in feline peripheral blood CD4+ T lymphocytes in vivo during the asymptomatic phase of infection
Murphy, B. G., Vapniarsky, N., Hillman, C., Castillo, D., McDonnel, S. J., Moore, P. F., Luciw, P. A., & Sparger, E. E. (2012) · Retrovirology · doi:10.1186/1742-4690-9-12 · Cited by 34
HIV-1 Latency and Eradication: Past, Present and Future
Datta, P. K., Kaminski, R., Hu, W., Pirrone, V., Sullivan, N. T., Nonnemacher, M. R., Dampier, W., Wigdahl, B. L., & Khalili, K. (2016) · Current HIV Research · doi:10.2174/1570162x14666160324125536 · Cited by 35
Insights into the HIV Latency and the Role of Cytokines
Hokello, J., Sharma, A. L., Dimri, M., & Tyagi, M. (2019) · Pathogens · doi:10.3390/pathogens8030137 · Cited by 34
The Mtb -HIV Syndemic Interaction: Why Treating M. tuberculosis Infection May Be Crucial for HIV-1 Eradication
Waters, R., Ndengane, M., Abrahams, M.-R., Diedrich, C. R., Wilkinson, R. J., & Coussens, A. K. (2020) · Future Virology · doi:10.2217/fvl-2019-0069 · Cited by 35
Substance Abuse, HIV-1 and Hepatitis
Parikh, N., Nonnemacher, M. R., Pirrone, V., Block, T. M., Mehta, A. S., & Wigdahl, B. L. (2012) · Current HIV Research · doi:10.2174/157016212803306023 · Cited by 34
Robust CD4+ and CD8+ T cell responses to SIV using mRNA‐transfected DC expressing autologous viral Ag
Melhem, N. M., Liu, X. D., Boczkowski, D., Gilboa, E., & Barratt‐Boyes, S. M. (2007) · European Journal of Immunology · doi:10.1002/eji.200636782 · Cited by 34
DNA immunization in combination with effective antiretroviral drug therapy controls viral rebound and prevents simian AIDS after treatment is discontinued
FULLER, D. H., Rajakumar, P. A., Wu, M. S., McMahon, C. W., Shipley, T., Fuller, J. T., Bazmi, A., Trichel, A. M., Allen, T. M., Mothé, B. R., et al. (2006) · Virology · doi:10.1016/j.virol.2005.12.008 · Cited by 34
Heterogeneous viral environment in a HIV spatial model
Brauner, C.-M., Jolly, D., Lorenzi, L., & Thiébaut, R. (2011) · Discrete and Continuous Dynamical Systems - B · doi:10.3934/dcdsb.2011.15.545 · Cited by 34
Genetic Selection for Context-Dependent Stochastic Phenotypes: Sp1 and TATA Mutations Increase Phenotypic Noise in HIV-1 Gene Expression
Miller‐Jensen, K., Skupsky, R., Shah, P. S., Arkin, A. P., & Schaffer, D. V. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003135 · Cited by 36
Differential HIV Epitope Processing in Monocytes and CD4 T Cells Affects Cytotoxic T Lymphocyte Recognition
Lazaro, E., Godfrey, S. B., Stamegna, P., Ogbechie, T., Kerrigan, C., Zhang, M., Walker, B. D., & Gall, S. L. (2009) · The Journal of Infectious Diseases · doi:10.1086/599837 · Cited by 34
Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis
Zhang, L., Meissner, E. G., Chen, J., & Su, L. (2010) · Science China Life Sciences · doi:10.1007/s11427-010-0059-7 · Cited by 34
Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease
Jochmans, D., Anders‐Össwein, M., Keuleers, I., Smeulders, L., Kräusslich, H., Kraus, G., & Müller, B. (2010) · Retrovirology · doi:10.1186/1742-4690-7-89 · Cited by 34
Evaluation of the Pathogenesis of Decreasing CD4+T Cell Counts in Human Immunodeficiency Virus Type 1–Infected Patients Receiving Successfully Suppressive Antiretroviral Therapy
Nies‐Kraske, E., Schacker, T. W., Condoluci, D. V., Orenstein, J. M., Brenchley, J. M., Fox, C. H., Daucher, M., Dewar, R. L., Urban, E., Hill, B. J., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/598980 · Cited by 34
Self-citation
HUSH, a Link Between Intrinsic Immunity and HIV Latency
Chougui, G., & Margottin-Goguet, F. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00224 · Cited by 35
Management of Antiretroviral Therapy for HIV Infection: Modelling when to Change Therapy
D'Amato, R. M., D’Aquila, R. T., & Wein, L. M. (1998) · Antiviral Therapy · doi:10.1177/135965359800300302 · Cited by 34
Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques
Lim, S., Lee, J., Osuna, C. E., Vikhe, P. P., Schalk, D. R., Chen, E., Fray, E. J., Kumar, M. R., SCHULTZ‐DARKEN, N. J., Rakasz, E. G., et al. (2024) · Science · doi:10.1126/science.adf7966 · Cited by 36
Self-citation
Variation in cell-associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator brain-and-muscle-ARNT-like-1
Chang, C. C., Naranbhai, V., Stern, J., Roche, M., Dantanarayana, A., Ke, R., Tennakoon, S., Solomon, A. E., Hoh, R., Hartogensis, W., et al. (2018) · AIDS · doi:10.1097/qad.0000000000001937 · Cited by 33
Impact of LEDGIN treatment during virus production on residual HIV-1 transcription
Vansant, G., Vranckx, L. S., Zurnic, I., Looveren, D. V., de Velde, P. V., Nobles, C. L., Gijsbers, R., Christ, F., & Debyser, Z. (2019) · Retrovirology · doi:10.1186/s12977-019-0472-3 · Cited by 33
HIV-1 Latency and Latency Reversal: Does Subtype Matter?
Sarabia, I., & Bosque, A. (2019) · Viruses · doi:10.3390/v11121104 · Cited by 34
Hypoxic microenvironment shapes HIV-1 replication and latency
Zhuang, X., Pedroza‐Pacheco, I., Nawroth, I., Kliszczak, A. E., Magri, A., Paes, W., Rubio, C. O., Yang, H., Ashcroft, M. A., Mole, D. R., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-1103-1 · Cited by 33
Interferon-induced IL-10 drives systemic T-cell dysfunction during chronic liver injury
Hackstein, C.-P., Spitzer, J., Symeonidis, K., Horvatic, H., Bedke, T., Steglich, B., Klein, S., Assmus, L. M., Odainic, A., Szlapa, J., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.02.026 · Cited by 33
HIV Quasispecies Dynamics during Pro-Active Treatment Switching: Impact on Multi-Drug Resistance and Resistance Archiving in Latent Reservoirs
von Kleist, M., Menz, S., Stocker, H., Arastéh, K., Schütte, C., & Huisinga, W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018204 · Cited by 34
Detection of peripheral HIV-1-specific memory B cells in patients untreated or receiving highly active antiretroviral therapy
Fondere, J.-M., Huguet, M., Yssel, H., Baillat, V., Reynes, J., de Perre, P. V., & Vendrell, J.-P. (2003) · AIDS · doi:10.1097/00002030-200311070-00006 · Cited by 33
International NeuroAIDS: prospects of HIV-1 associated neurological complications
Trujillo, J. R., Jaramillo‐Rangel, G., Ortega‐Martínez, M., de Oliveira, A. C. P., Vidal, J. E., Bryant, J., & Gallo, R. C. (2005) · Cell Research · doi:10.1038/sj.cr.7290374 · Cited by 33
Underlying mechanisms of HIV-1 latency
Romani, B., & Allahbakhshi, E. (2017) · Virus Genes · doi:10.1007/s11262-017-1443-1 · Cited by 34
Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study
Sgadari, C., Monini, P., Tripiciano, A., Picconi, O., Casabianca, A., Orlandi, C., Moretti, S., Francavilla, V., Arancio, A., Paniccia, G., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00233 · Cited by 35
The Role of Immunomodulatory Receptors in the Pathogenesis of HIV Infection: A Therapeutic Opportunity for HIV Cure?
Chen, H., Moussa, M., & Catálfamo, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01223 · Cited by 33
T–cell induced pathogenesis in HIV: bystander effects and latent infection
Krakauer, D. C., & Nowak, M. A. (1999) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1999.0745 · Cited by 33
Relationship between CD38 expression on peripheral blood T‐cells and monocytes, and response to antiretroviral therapy: A one‐year longitudinal study of a cohort of chronically infected ART‐naive HIV‐1+ patients
Almeida, M. D. G., Cordero, M., Almeida, J., & Órfão, A. (2006) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20144 · Cited by 33
Surrogate Markers for Disease Progression in Treated HIV Infection
Ghani, A. C., de Wolf, F., Ferguson, N. M., Donnelly, C. A., Coutinho, R. A., Miedema, F. F., Goudsmit, J., & Anderson, R. M. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200111010-00004 · Cited by 33
Normal Telomere Lengths in Naive and Memory CD4+ T Cells in HIV Type 1 Infection: A Mathematical Interpretation
Wolthers, K. C., Noest, A. J., Otto, S. A., Miedema, F. F., & de Boer, R. J. (1999) · AIDS Research and Human Retroviruses · doi:10.1089/088922299310340 · Cited by 33
HIV-1–Specific CD4 Helper Function in Persons With Chronic HIV-1 Infection on Antiviral Drug Therapy as Measured by ELISPOT After Treatment With an Inactivated, gp120-Depleted HIV-1 in Incomplete Freund's Adjuvant
Moss, R. B., Webb, E., Giermakowska, W., Jensen, F. C., Savary, J. R., Wallace, M. R., & Carlo, D. J. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200007010-00012 · Cited by 33
The AIDS Pandemic in Historic Perspective
Kazanjian, P. H. (2012) · Journal of the History of Medicine and Allied Sciences · doi:10.1093/jhmas/jrs061 · Cited by 32
Elite control of HIV: is this the right model for a functional cure?
Cockerham, L. R., & Hatano, H. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.11.003 · Cited by 32
Elevated Plasma Viral Loads in Romidepsin-Treated Simian Immunodeficiency Virus-Infected Rhesus Macaques on Suppressive Combination Antiretroviral Therapy
Prete, G. Q. D., Oswald, K. A., Lara, A., Shoemaker, R. S., Smedley, J. V., MacAllister, R., Coalter, V. J., Wiles, A., Wiles, R., Li, Y., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02625-15 · Cited by 32
CRISPR/Cas9 Genome Editing to Disable the Latent HIV-1 Provirus
Panfil, A. R., London, J. A., Green, P. L., & Yoder, K. E. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03107 · Cited by 34
Transcriptional Circuit Fragility Influences HIV Proviral Fate
Morton, E. L., Forst, C. V., Zheng, Y., DePaula-Silva, A. B., Ramirez, N.-G. P., Planelles, V., & D’Orso, I. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.007 · Cited by 33
The Clonal Expansion Dynamics of the HIV-1 Reservoir: Mechanisms of Integration Site-Dependent Proliferation and HIV-1 Persistence
Yeh, Y.-H. J., Yang, K., Razmi, A., & Ho, Y. (2021) · Viruses · doi:10.3390/v13091858 · Cited by 35
An exploratory algorithm to identify intra-host recombinant viral sequences
Salemi, M., Gray, R. R., & Goodenow, M. M. (2008) · Molecular Phylogenetics and Evolution · doi:10.1016/j.ympev.2008.08.017 · Cited by 32
2B4 expression on natural killer cells increases in HIV-1 infected patients followed prospectively during highly active antiretroviral therapy
Ostrowski, S. R., Ullum, H., Pedersen, B. K., Gerstoft, J., & Katzenstein, T. L. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02869.x · Cited by 32
Modelling of HIV infection: Vaccine readiness, drug effectiveness and therapeutical failures
Xia, X. (2006) · Journal of Process Control · doi:10.1016/j.jprocont.2006.10.007 · Cited by 32
Primary Cell Model for Activation-Inducible Human Immunodeficiency Virus
Burke, B. P., Brown, H. J., Marsden, M. D., Bristol, G. C., Vatakis, D. N., & Zack, J. A. (2007) · Journal of Virology · doi:10.1128/jvi.02838-06 · Cited by 33
Changes in HIV reservoirs during long-term antiretroviral therapy
Hong, F. F., & Mellors, J. W. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000119 · Cited by 34
γδ T cells: an immunotherapeutic approach for HIV cure strategies
Garrido, C., Clohosey, M. L., Whitworth, C. P., Hudgens, M. G., Margolis, D. M., & Soriano-Sarabia, N. (2018) · JCI Insight · doi:10.1172/jci.insight.120121 · Cited by 32
Substance P enhances HIV-1 replication in latently infected human immune cells
Li, Y., Douglas, S. D., Li, S., Sun, S., & Ho, W. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00439-8 · Cited by 32
Eradication of HIV from Tissue Reservoirs: Challenges for the Cure
Rose, R., Nolan, D. J., Maidji, E., Stoddart, C. A., Singer, E. J., Lamers, S. L., & McGrath, M. S. (2017) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2017.0072 · Cited by 35
Combination of Biological Screening in a Cellular Model of Viral Latency and Virtual Screening Identifies Novel Compounds That Reactivate HIV-1
Gallastegui, E., Marshall, B. L., Vidal, D., Sánchez‐Duffhues, G., Collado, J. A., Álvarez‐Fernández, C., Luque, N., Terme, J.-M., Gatell, J. M., Sánchez‐Palomino, S., et al. (2012) · Journal of Virology · doi:10.1128/jvi.05972-11 · Cited by 31
In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase Inhibitors
Banga, R., Procopio, F. A., Cavassini, M. L., & Perreau, M. (2015) · Journal of Virology · doi:10.1128/jvi.02359-15 · Cited by 31
Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies
Darcis, G., Das, A. T., & Berkhout, B. (2018) · Viruses · doi:10.3390/v10040157 · Cited by 31
Reversible Human Immunodeficiency Virus Type-1 Latency in Primary Human Monocyte-Derived Macrophages Induced by Sustained M1 Polarization
Graziano, F., Aimola, G., Forlani, G., Turrini, F., Accolla, R. S., Vicenzi, E., & Poli, G. (2018) · Scientific Reports · doi:10.1038/s41598-018-32451-w · Cited by 31
Cell-Associated HIV-1 Unspliced-to-Multiply-Spliced RNA Ratio at 12 Weeks of ART Predicts Immune Reconstitution on Therapy
Scherpenisse, M., Kootstra, N. A., Bakker, M. E., Berkhout, B., & Pasternak, A. O. (2021) · mBio · doi:10.1128/mbio.00099-21 · Cited by 31
Fused deposition modeling three-dimensional printing of flexible polyurethane intravaginal rings with controlled tunable release profiles for multiple active drugs
Chen, Y. A., Traoré, Y. L., Walker, L., Yang, S., & Ho, E. A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01133-6 · Cited by 31
An HIV infection model based on a vectored immunoprophylaxis experiment
Wang, X., & Wang, W. (2012) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2012.08.023 · Cited by 31
Decreases in plasma TNF-αlevel and IFN-γmRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV-infected patients
Brazille, P., Dereuddre‐Bosquet, N., Leport, C., Clayette, P., Boyer, O., Vilde, J.-L., Dormont, D., & Benvéniste, O. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02064.x · Cited by 32
Stability of HIV-1 Nucleic Acids in Dried Blood Spot Samples for HIV-1 Drug Resistance Genotyping
Aitken, S. C., Wallis, C. L., Stevens, W. S., de Wit, T. F. R., & Schuurman, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131541 · Cited by 31
Different Pathways Leading to Integrase Inhibitors Resistance
Thierry, E., Deprez, E., & Delelis, O. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02165 · Cited by 37
Longitudinal imaging of HIV-1 spread in humanized mice with parallel 3D immunofluorescence and electron tomography
Kieffer, C., Ladinsky, M. S., Ninh, A., Galimidi, R. P., & Björkman, P. J. (2017) · eLife · doi:10.7554/elife.23282 · Cited by 31
Assays to Measure Latency, Reservoirs, and Reactivation
Siliciano, J. D., & Siliciano, R. F. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_75 · Cited by 31
Self-citation
Peptides Derived from HIV-1 Integrase that Bind Rev Stimulate Viral Genome Integration
Levin, A., Hayouka, Z., Helfer, M., Brack‐Werner, R., Friedler, A., & Loyter, A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004155 · Cited by 31
The importance of lymphocyte trafficking in regulating blood lymphocyte levels during HIV and SIV infections
Rosenberg, Y. J., & Janossy, G. (1999) · Seminars in Immunology · doi:10.1006/smim.1999.0169 · Cited by 31
Interleukin-7 Induces HIV Type 1 Outgrowth From Peripheral Resting CD4+ T Cells
Lehrman, G. K., Ylisastigui, L., Bosch, R. J., & Margolis, D. M. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200408150-00015 · Cited by 31
Macrophage Protection Against Human Immunodeficiency Virus or Herpes Simplex Virus by Red Blood Cell-Mediated Delivery of a Heterodinucleotide of Azidothymidine and Acyclovir
Rossi, L., Brandi, G., Schiavano, G. F., Balestra, E., Millo, E., Scarfı̀, S., Damonte, G., GASPARINI, A., Magnani, M., Perno, C. F., et al. (1998) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1998.14.435 · Cited by 31
Rapid Viral Decay in Simian Immunodeficiency Virus-Infected Macaques Receiving Quadruple Antiretroviral Therapy
Brandin, E., Thorstensson, R., Bonhoeffer, S., & Albert, J. (2006) · Journal of Virology · doi:10.1128/jvi.00394-06 · Cited by 31
Infection of CD4+ Memory T Cells by HIV-1 Requires Expression of Phosphodiesterase 4
Sun, Y., Li, L., Lau, F. K., Beavo, J. A., & Clark, E. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.1755 · Cited by 31

Authors: Chun, T.-W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J. A., Taylor, H., Hermankova, M., Chadwick, K., Margolick, J., Quinn, T. C., Kuo, Y.-H., Brookmeyer, R., Zeiger, M. A., Barditch-Crovo, P., & Siliciano, R. F.
Affiliations: Johns Hopkins University (US)
National Institutes of Health (US)
ORCID: Chun, Tae-Wook
DiGiuseppe, Joseph A.
Margolick, Joseph
Quinn, Thomas C.
Kuo, Yen-Hong
Zeiger, Martha A.
Siliciano, Robert F.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 1997-05
Volume: 387
Issue: 6629
Pages: 183-188
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/387183a0
OpenAlex: W2030844138
Cited by: 2,050
References: 29
Citations by year: 2026: 29 · 2025: 47 · 2024: 48 · 2023: 59 · 2022: 54 · 2021: 56 · 2020: 80 · 2019: 79 · 2018: 102 · 2017: 81 · 2016: 98 · 2015: 79 · 2014: 86 · 2013: 87 · 2012: 74
FWCI: 25.32
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Topics: Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords: HIV-1, latent viral reservoir, CD4+ T cells, integrated provirus, viral persistence, asymptomatic HIV infection, activated T cells, macrophages, viral DNA, viral RNA, antiretroviral therapy
MeSH terms: Cells, Cultured, DNA, Viral, Humans, Immunologic Memory, Lymph Nodes, Lymphocyte Activation, Macrophages, Proviruses, Virus Replication, CD4-Positive T-Lymphocytes, HIV-1, HIV Infections, Polymerase Chain Reaction, Virus Integration, Leukocyte Common Antigens, Virus Latency, Coculture Techniques, Anti-HIV Agents, Viral Load

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks